Alta Advisers’s Moderna MRNA Stock Holding History

Alta Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$531K	Buy	+2,755	New	+$297K	0.08%	153
2024 Q4	–	Sell	-1,000	Closed	-$66.8K	–	316
2024 Q3	$66.8K	Hold	1,000	–	–	0.03%	378
2024 Q2	$119K	Hold	1,000	–	–	0.06%	215
2024 Q1	$107K	Hold	1,000	–	–	0.05%	260
2023 Q4	$99.4K	Hold	1,000	–	–	0.05%	259
2023 Q3	$103K	Hold	1,000	–	–	0.06%	226
2023 Q2	$122K	Hold	1,000	–	–	0.07%	191
2023 Q1	$154K	Hold	1,000	–	–	0.09%	135
2022 Q4	$180K	Hold	1,000	–	–	0.11%	111
2022 Q3	$118K	Buy	+1,000	New	+$152K	0.07%	161

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Alta Advisers's MRNA Position: Q3 2026 in Review

Alta Advisers opened a new position in Moderna (MRNA) in Q3 2026: 2,755 shares worth $531K. The stake represents 0.08% of the portfolio and ranks #153 among its holdings. This is a return to the name: Alta Advisers previously reported a position in MRNA as recently as Q3 2024.

Alta Advisers first reported a position in MRNA in Q3 2022 and has held it in 10 quarters since. 771 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Alta Advisers held 2,755 shares of Moderna worth $531K as of Q3 2026.
Moderna was a new Alta Advisers position in Q3 2026.
Moderna made up 0.08% of Alta Advisers's portfolio in Q3 2026, its #153 holding.
Alta Advisers first reported a position in Moderna in Q3 2022 and has held it in 10 quarters since.
771 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Alta Advisers's 13F filing for Q3 2026, filed 2 Nov 2026.